These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28720321)

  • 1. No evidence for progressive deterioration in stimulated insulin secretion in renal transplant recipients after 12years tacrolimus exposure.
    Gelens MACJ; van Hooff JP; Usvyat L; Christiaans MH
    J Diabetes Complications; 2017 Sep; 31(9):1384-1388. PubMed ID: 28720321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta Cell Function and Insulin Resistance After Conversion from Tacrolimus Twice-Daily to Extended-Release Tacrolimus Once-Daily in Stable Renal Transplant Recipients.
    Ruangkanchanasetr P; Sanohdontree N; Supaporn T; Sathavarodom N; Satirapoj B
    Ann Transplant; 2016 Dec; 21():765-774. PubMed ID: 27980321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients.
    Handisurya A; Kerscher C; Tura A; Herkner H; Payer BA; Mandorfer M; Werzowa J; Winnicki W; Reiberger T; Kautzky-Willer A; Pacini G; Säemann M; Schmidt A
    PLoS One; 2016; 11(1):e0145319. PubMed ID: 26735686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin hyposecretion in nondiabetic, tacrolimus-treated renal transplant recipients more than 6 months posttransplantation.
    Ravindran VK; Moore RH; Dunseath G; Luzio SD; Owens DR; Baboolal K
    Transplantation; 2009 Jun; 87(12):1870-6. PubMed ID: 19543067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tacrolimus versus cyclosporine on glucose metabolism of pancreas and kidney recipients in the late (> 8 years) posttransplant period.
    Havrdova T; Jedinakova T; Lipar K; Skibova J; Saudek F
    Transplant Proc; 2011 Nov; 43(9):3270-2. PubMed ID: 22099774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dynamics of glucose metabolism under calcineurin inhibitors in the first year after renal transplantation in nonobese patients.
    David-Neto E; Lemos FC; Fadel LM; Agena F; Sato MY; Coccuza C; Pereira LM; de Castro MC; Lando VS; Nahas WC; Ianhez LE
    Transplantation; 2007 Jul; 84(1):50-5. PubMed ID: 17627237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcineurin inhibitors acutely improve insulin sensitivity without affecting insulin secretion in healthy human volunteers.
    Øzbay LA; Møller N; Juhl C; Bjerre M; Carstens J; Rungby J; Jørgensen KA
    Br J Clin Pharmacol; 2012 Apr; 73(4):536-45. PubMed ID: 21988494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediabetes in Pediatric Recipients of Liver Transplant: Mechanism and Risk Factors.
    Perito ER; Lustig RH; Rosenthal P
    J Pediatr; 2017 Mar; 182():223-231.e3. PubMed ID: 28041666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus decreases insulin sensitivity without reducing fasting insulin concentration: a 2-year follow-up study in kidney transplant recipients.
    Chen QJ; Li J; Zuo SR; Zhang YP; Jia SJ; Yuan H; Liu SK; Cheng K; Ming YZ; Zuo XC; Luo AJ; Xie WZ; Cai JJ; Yang M; Wang JL
    Ren Fail; 2015 May; 37(4):601-6. PubMed ID: 25644968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus reversibly reduces insulin secretion in paediatric renal transplant recipients.
    Filler G; Neuschulz I; Vollmer I; Amendt P; Hocher B
    Nephrol Dial Transplant; 2000 Jun; 15(6):867-71. PubMed ID: 10831643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy.
    Sato T; Inagaki A; Uchida K; Ueki T; Goto N; Matsuoka S; Katayama A; Haba T; Tominaga Y; Okajima Y; Ohta K; Suga H; Taguchi S; Kakiya S; Itatsu T; Kobayashi T; Nakao A
    Transplantation; 2003 Nov; 76(9):1320-6. PubMed ID: 14627910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus and angiotensin receptor blockers associated with changes in serum adiponectin level in new-onset diabetes after renal transplantation: single-center cross-sectional analysis.
    Nishimura K; Kishikawa H; Kato T; Kobayashi Y; Fujii N; Takahara S; Ichikawa Y
    Transpl Int; 2009 Jul; 22(7):694-701. PubMed ID: 19254242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction.
    Boots JMM; van Duijnhoven EM; Christiaans MHL; Wolffenbuttel BHR; van Hooff JP
    J Am Soc Nephrol; 2002 Jan; 13(1):221-227. PubMed ID: 11752041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and insulin secretion in renal transplant recipients with hepatitis C.
    Uchida J; Iwai T; Machida Y; Kuwabara N; Kabei K; Kumada N; Nakatani T
    Transplant Proc; 2013 May; 45(4):1540-3. PubMed ID: 23726615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immunosuppression.
    van Duijnhoven EM; Christiaans MHL; Boots JMM; Nieman FHM; Wolffenbuttel BHR; van Hooff JP
    J Am Soc Nephrol; 2002 Jan; 13(1):213-220. PubMed ID: 11752040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of tacrolimus on glucose metabolism before and after renal transplantation: a prospective study.
    Duijnhoven EMV; Boots JMM; Christiaans MHL; Wolffenbuttel BHR; Hooff JPV
    J Am Soc Nephrol; 2001 Mar; 12(3):583-588. PubMed ID: 11181807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
    Gallon LG; Winoto J; Chhabra D; Parker MA; Leventhal JR; Kaufman DB
    Transplantation; 2007 May; 83(10):1324-9. PubMed ID: 17519781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin Secretion and Insulin Resistance Trajectories over 1 Year after Kidney Transplantation: A Multicenter Prospective Cohort Study.
    Bang JB; Oh CK; Kim YS; Kim SH; Yu HC; Kim CD; Ju MK; So BJ; Lee SH; Han SY; Jung CW; Kim JK; Lee SH; Jeon JY
    Endocrinol Metab (Seoul); 2020 Dec; 35(4):820-829. PubMed ID: 33202516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose metabolism before and after conversion from cyclosporine microemulsion to tacrolimus in stable renal recipients.
    Gelens MA; Christiaans MH; van Hooff JP
    Nephrol Dial Transplant; 2008 Feb; 23(2):701-6. PubMed ID: 17999993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No change in insulin sensitivity in renal transplant recipients converted from standard to once-daily prolonged release tacrolimus.
    Midtvedt K; Jenssen T; Hartmann A; Vethe NT; Bergan S; Havnes K; Åsberg A
    Nephrol Dial Transplant; 2011 Nov; 26(11):3767-72. PubMed ID: 21471328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.